Cabinet to assess 20 drugs in 2016 under new rules
Ministers charged with making life or death calls
Twenty expensive new medicines are expected to go to cabinet for approval this year, the Department of Health has said.
Under a radically changed approval process, the government now has to approve expensive medicines before the Health Service Executive (HSE) will pay for them.
New drugs to treat cancer, high cholesterol and cystic fibrosis are at various stages of the assessment process at present. The cumulative cost of these medicines is about €300 million per...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Healthcare software developers claim they could cut waiting lists by 25%
The Irish Hospital Consultants Association has warned that the numbers waiting for either treatment or a consultation will soon increase to over one million patients
Tony O’Brien: The apparent slow collapse of Sláintecare deserves more than a shrug of the shoulders
Downplaying and media management dominated the government’s response to the resignation of Laura Magahy and Tom Keane from the Sláintecare programme
‘Reinforcing’ of existing HSE structures played role in Sláintecare resignations
More departures from the Sláintecare Implementation Advisory Council could ensue in the coming weeks, as members weigh up their next move
HSE never used Citywest conference centre as isolation hub despite multimillion refurbishment
Executive leased conference centre for use as an overspill facility but never used the conference centre despite millions being spent making it habitable